Association of KDR (rs2071559, rs1870377), CFH (rs1061170, rs1410996) genes variants and serum levels with pituitary adenoma

Mol Genet Genomic Med. 2024 Jan;12(1):e2289. doi: 10.1002/mgg3.2289. Epub 2023 Oct 6.

Abstract

Introduction: Pituitary adenomas (PA) are slow-growing, benign tumors that usually do not metastasize to other body organs. Although they are referred to as benign, tumor growth can eventually put pressure on nearby structures, spread to surrounding tissues, and cause symptoms. The exact cause of PA is unknown, and the pathogenesis is multifactorial.

Methods: Our study included PA patients and healthy volunteers. Genomic DNA was extracted using the DNA salting-out method. All participants were genotyped for the KDR rs2071559, rs1870377, CFH rs1061170, and rs1410996 polymorphisms. Serum levels of KDR and CFH were examined using the ELISA method.

Results: The results of the present study showed that KDR rs2071559 A allele was associated with the occurrence of PA, hormonally active PA, invasive PA, and PA without recurrence development. KDR rs1870377 increased the probability of invasive PA and PA recurrence. CFH rs1061170 C allele was associated with hormonally active PA and the T allele was associated with non-invasive PA development.

Conclusion: KDR rs2071559, rs1870377, and CFH rs1061170 could be potential biomarkers associated with PA.

Keywords: CFH; KDR; hormonal activity; invasiveness; pituitary adenoma; recurrence; rs1061170; rs1410996; rs1870377; rs2071559; serum levels.

MeSH terms

  • DNA
  • Genetic Predisposition to Disease*
  • Genotype
  • Humans
  • Pituitary Neoplasms*
  • Polymorphism, Single Nucleotide
  • Vascular Endothelial Growth Factor Receptor-2 / genetics

Substances

  • DNA
  • KDR protein, human
  • Vascular Endothelial Growth Factor Receptor-2
  • CFH protein, human